Ticker LaunchSPAC · Liquidated
Biotech Acquisition Company
Biotech Acquisition Company is a blank-check company (SPAC) that raised $200M in its initial public offering on Jan 27, 2021, listing on Nasdaq Capital Market. It did not complete a business combination and liquidated around Feb 2, 2023, returning the trust to public shareholders. Cantor led the IPO. Ellenoff Grossman & Schole advised the SPAC and Reed Smith advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Jan 27, 2021
- IPO size
- $200M
- IPO exchange
- Nasdaq Capital Market
- IPO underwriters
- Cantor
- SPAC counsel (IPO)
- Ellenoff Grossman & Schole and Maples and Calder
- Underwriters' counsel (IPO)
- Reed Smith
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jan 27, 2021
- All filings on EDGAR CIK 1825413
Other SPAC IPOs from 2021
- DiamondHead Holdings Corp.Jan 27, 2021 · $300M
- D & Z Media Acquisition Corp.Jan 27, 2021 · $250M
- Science Strategic Acquisition Corp. AlphaJan 27, 2021 · $270M
- LMF Acquisition Opportunities IncJan 27, 2021 · $90M
- Northern Star Investment Corp. IIJan 27, 2021 · $350M
- Climate Real Impact Solutions II Acquisition CorpJan 27, 2021 · $210M